January 22, 2018 / 1:58 PM / a month ago

BRIEF-ImmunoPrecise To Invest In Single Cell's Foundational Technology

Jan 22 (Reuters) - Immunoprecise Antibodies Ltd:

* IMMUNOPRECISE TO STRATEGICALLY INVEST IN FOUNDATIONAL NEXT GENERATION ANTIBODY DISCOVERY TECHNOLOGY

* IMMUNOPRECISE ANTIBODIES - ‍AGREED TO INVEST $5 MILLION IN EXPANSION & DEVELOPMENT OF PRODUCTION CAPABILITY FOR SINGLE CELL‘S FOUNDATIONAL TECHNOLOGY​

* IMMUNOPRECISE ANTIBODIES - INVESTMENT WILL RESULT IN CO OWNING ABOUT 10% OF ISSUED AND OUTSTANDING SHARES OF SINGLE CELL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below